BMB Reports

생화학분자생물학회 (Korean Society for Biochemistry and Molecular Biology)
권호 표지
DOI QR코드

DOI QR Code

Neuromedin B modulates phosphate-induced vascular calcification

  • Park, Hyun-Joo (Department of Oral Physiology, School of Dentistry, Pusan National University) ;
  • Kim, Mi-Kyoung (Department of Oral Physiology, School of Dentistry, Pusan National University) ;
  • Kim, Yeon (Department of Oral Physiology, School of Dentistry, Pusan National University) ;
  • Kim, Hyung Joon (Department of Oral Physiology, School of Dentistry, Pusan National University) ;
  • Bae, Soo-Kyung (Periodontal Disease Signaling Network Research Center (MRC), School of Dentistry, Pusan National University) ;
  • Bae, Moon-Kyoung (Department of Oral Physiology, School of Dentistry, Pusan National University)
  • 투고 : 2021.07.08
  • 심사 : 2021.10.06
  • 발행 : 2021.11.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Vascular calcification is the heterotopic accumulation of calcium phosphate salts in the vascular tissue and is highly correlated with increased cardiovascular morbidity and mortality. In this study, we found that the expression of neuromedin B (NMB) and NMB receptor is upregulated in phosphate-induced calcification of vascular smooth muscle cells (VSMCs). Silencing of NMB or treatment with NMB receptor antagonist, PD168368, inhibited the phosphate-induced osteogenic differentiation of VSMCs by inhibiting Wnt/β-catenin signaling and VSMC apoptosis. PD168368 also attenuated the arterial calcification in cultured aortic rings and in a rat model of chronic kidney disease. The results of this study suggest that NMB-NMB receptor axis may have potential therapeutic value in the diagnosis and treatment of vascular calcification.

키워드

과제정보

This research was supported by the National Research Foundation of Korea grant, funded by the Korean government (MSIT) (NRF-2018R1A5A2023879) (to M-K Bae), and Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2019R1I1A1A01061 377) (to H-J Park).

참고문헌

  1. Johnson RC, Leopold JA, and Loscalzo J (2006) Vascular calcification: pathobiological mechanisms and clinical implications. Circ Res 99, 1044-1059 https://doi.org/10.1161/01.RES.0000249379.55535.21
  2. Singh A, Tandon S, and Tandon C (2021) An update on vascular calcification and potential therapeutics. Mol Biol Rep 48, 887-896 https://doi.org/10.1007/s11033-020-06086-y
  3. Leopold JA (2015) Vascular calcification: mechanisms of vascular smooth muscle cell calcification. Trends Cardiovasc Med 25, 267-274 https://doi.org/10.1016/j.tcm.2014.10.021
  4. McCarty MF and DiNicolantonio JJ (2014) The molecular biology and pathophysiology of vascular calcification. Postgrad Med 126, 54-64 https://doi.org/10.3810/pgm.2014.03.2740
  5. Jensen RT, Battey JF, Spindel ER, and Benya RV (2008) International union of pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev 60, 1-42 https://doi.org/10.1124/pr.107.07108
  6. Majumdar ID and Weber HC (2011) Biology of mammalian bombesin-like peptides and their receptors. Curr Opin Endocrinol Diabetes Obes 18, 68-74 https://doi.org/10.1097/MED.0b013e328340ff93
  7. Gonzalez N, Moody TW, Igarashi H, Ito T, and Jensen RT (2008) Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes 15, 58-64 https://doi.org/10.1097/MED.0b013e3282f3709b
  8. Choi Y, Heo SC, Kim YN et al (2020) Gastrin-releasing peptide (GRP) stimulates osteoclastogenesis in periodontitis. Cells 10, 50 https://doi.org/10.3390/cells10010050
  9. Yeo CE, Kang WY, Seong SJ et al (2017) Neuromedin B and its receptor silencing suppresses osteoclast generation by modulating precursor proliferation via M-CSF/c-Fms/D-type cyclins. Exp Cell Res 359, 112-119 https://doi.org/10.1016/j.yexcr.2017.08.003
  10. Saito H, Nakamachi T, Inoue K et al (2013) Autocrine effects of neuromedin B stimulate the proliferation of rat primary osteoblasts. J Endocrinol 217, 141-150 https://doi.org/10.1530/JOE-12-0488
  11. Cannata-Andia JB, Roman-Garcia P, and Hruska K (2011) The connections between vascular calcification and bone health. Nephrol Dial Transplant 26, 3429-3436 https://doi.org/10.1093/ndt/gfr591
  12. Park HJ, Kim Y, Kim MK et al (2020) Inhibition of gastrin-releasing peptide attenuates phosphate-induced vascular calcification. Cells 9, 737 https://doi.org/10.3390/cells9030737
  13. Jono S, McKee MD, Murry CE et al (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87, E10-7
  14. Gonzalez N, Mantey SA, Pradhan TK et al (2009) Characterization of putative GRP- and NMB-receptor antagonist's interaction with human receptors. Peptides 30, 1473-1486 https://doi.org/10.1016/j.peptides.2009.05.007
  15. Cai T, Sun D, Duan Y et al (2016) WNT/beta-catenin signaling promotes VSMCs to osteogenic transdifferentiation and calcification through directly modulating Runx2 gene expression. Exp Cell Res 345, 206-217 https://doi.org/10.1016/j.yexcr.2016.06.007
  16. Wu D and Pan W (2010) GSK3: a multifaceted kinase in Wnt signaling. Trends Biochem Sci 35, 161-168 https://doi.org/10.1016/j.tibs.2009.10.002
  17. Proudfoot D, Skepper JN, Hegyi L, Bennett MR, Shanahan CM, and Weissberg PL (2000) Apoptosis regulates human vascular calcification in vitro: evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 87, 1055-1062 https://doi.org/10.1161/01.RES.87.11.1055
  18. Akiyoshi T, Ota H, Iijima K et al (2016) A novel organ culture model of aorta for vascular calcification. Atherosclerosis 244, 51-58 https://doi.org/10.1016/j.atherosclerosis.2015.11.005
  19. Shobeiri N, Adams MA, and Holden RM (2010) Vascular calcification in animal models of CKD: A review. Am J Nephrol 31, 471-481 https://doi.org/10.1159/000299794
  20. Park HJ, Kim SR, Bae SK et al (2009) Neuromedin B induces angiogenesis via activation of ERK and Akt in endothelial cells. Exp Cell Res 315, 3359-3369 https://doi.org/10.1016/j.yexcr.2009.08.009
  21. Martinez A, Zudaire E, Julian M, Moody TW, and Cuttitta F (2005) Gastrin-releasing peptide (GRP) induces angiogenesis and the specific GRP blocker 77427 inhibits tumor growth in vitro and in vivo. Oncogene 24, 4106-4113 https://doi.org/10.1038/sj.onc.1208581
  22. Park HJ, Kim MK, Kim Y et al (2017) Gastrin-releasing peptide promotes the migration of vascular smooth muscle cells through upregulation of matrix metalloproteinase-2 and -9. BMB Rep 50, 628-633 https://doi.org/10.5483/BMBRep.2017.50.12.158
  23. Kim MK, Park HJ, Kim Y, Kim HJ, Bae SK, and Bae MK (2017) Gastrin-releasing peptide induces monocyte adhesion to vascular endothelium by upregulating endothelial adhesion molecules. Biochem Biophys Res Commun 485, 542-549 https://doi.org/10.1016/j.bbrc.2017.01.058
  24. Rodriguez-Granillo GA, Carrascosa P, and Bruining N (2016) Progression of coronary artery calcification at the crossroads: sign of progression or stabilization of coronary atherosclerosis? Cardiovasc Diagn Ther 6, 250-258 https://doi.org/10.21037/cdt.2016.03.03
  25. Schlieper G, Schurgers L, Brandenburg V, Reutelingsperger C, and Floege J (2016) Vascular calcification in chronic kidney disease: an update. Nephrol Dial Transplant 31, 31-39 https://doi.org/10.1093/ndt/gfv111
  26. Evenepoel P, Opdebeeck B, David K, and D'Haese PC (2019) Bone-vascular axis in chronic kidney disease. Adv Chronic Kidney Dis 26, 472-483 https://doi.org/10.1053/j.ackd.2019.09.006
  27. Cong J, Cheng B, Liu J, and He P (2021) RTEF-1 inhibits vascular smooth muscle cell calcification through regulating Wnt/beta-Catenin signaling pathway. Calcif Tissue Int 109, 203-214 https://doi.org/10.1007/s00223-021-00833-4
  28. Song WJ, Song EA, Jung MS et al (2015) Phosphorylation and inactivation of glycogen synthase kinase 3beta (GSK3beta) by dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A). J Biol Chem 290, 2321-2333 https://doi.org/10.1074/jbc.M114.594952
  29. Znorko B, Oksztulska-Kolanek E, Michalowska M, Kaminski T, and Pawlak K (2017) Does the OPG/RANKL system contribute to the bone-vascular axis in chronic kidney disease? A systematic review. Adv Med Sci 62, 52-64 https://doi.org/10.1016/j.advms.2016.08.001
  30. Dai Z, Zhu J, Huang H et al (2020) Expression and clinical value of gastrin-releasing peptide precursor in nephropathy and chronic kidney disease. Nephrology (Carlton) 25, 398-405 https://doi.org/10.1111/nep.13642
  31. Tamagaki K, Yuan Q, Ohkawa H et al (2006) Severe hyper-parathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrol Dial Transplant 21, 651-659 https://doi.org/10.1093/ndt/gfi273